Otsuka F, Shima A, Ishibashi Y
Department of Dermatology, Faculty of Medicine, University of Tokyo, Japan.
J Invest Dermatol. 1989 May;92(5 Suppl):231S-3S. doi: 10.1111/1523-1747.ep13075610.
Clinical evidence of malignant epithelial tumors developing on the lesions of porokeratosis has accumulated. To determine the cytologic basis for the malignant change of porokeratosis, the nuclear DNA content of epidermal cells from porokeratosis lesions was measured using microfluorometry. A total of 42% of 33 porokeratosis skin lesions in eight of the 16 patients showed DNA polyploidization in the epidermis. Most of the porokeratosis skin lesions, with or without DNA polyploidization, increased cell proportions in the S and G2/M phase range. These findings suggest that porokeratosis is undergoing the neoplastic process, and is the precursor skin manifestation of malignant tumors.
已有关于在汗孔角化症病变基础上发生恶性上皮肿瘤的临床证据积累。为确定汗孔角化症恶变的细胞学基础,采用显微荧光测定法测量了汗孔角化症病变表皮细胞的核DNA含量。16例患者中有8例共33处汗孔角化症皮肤病变,其中42%的病变表皮出现DNA多倍体化。大多数汗孔角化症皮肤病变,无论有无DNA多倍体化,S期和G2/M期细胞比例均增加。这些发现提示汗孔角化症正经历肿瘤形成过程,是恶性肿瘤的前驱性皮肤表现。